KORU MEDICAL SYSTEMS, INC. (KRMD) Quick Ratio
- Quick ratio · latest quarter: Value (m); Formula and calculation Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-06-30..
Quick ratio
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Quick ratio · latest quarter | (m) | Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Cash, securities and trade receivables | (m) | Cash and Cash Equivalents, at Carrying Value · Accounts Receivable, after Allowance for Credit Loss, Current |
| Current obligations | 7.18M USD | Liabilities, Current |
| Cash and equivalents | 8.29M USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | (m) | |
| Customer receivables | (m) | Accounts Receivable, after Allowance for Credit Loss, Current |
| Inventory · excluded from quick assets | 4.51M USD | Inventory, Net |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Cash, securities and trade receivables (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory · excluded from quick assets (USD) | Quick ratio |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | $7.18M | $8.29M | (m) | (m) | $4.51M | (m) |
| 2026-03-31 | (m) | $8.85M | $8.77M | (m) | $5.98M | $4.48M | (m) |
| 2025-12-31 | (m) | $8.19M | $8.87M | (m) | $6.21M | $3.68M | (m) |
| 2025-09-30 | (m) | $7.83M | $8.46M | (m) | $5.41M | $4.41M | (m) |
| 2025-06-30 | (m) | $6.05M | $8.05M | (m) | $4.93M | $3.95M | (m) |
| 2025-03-31 | (m) | $7.80M | $8.74M | (m) | $5.95M | $3.28M | (m) |
| 2024-12-31 | (m) | $7.20M | $9.58M | (m) | $5.72M | $2.80M | (m) |
| 2024-09-30 | (m) | $6.32M | $8.81M | (m) | $5.16M | $3.93M | (m) |
| 2024-06-30 | (m) | $5.14M | $10.46M | (m) | $5.85M | $2.59M | (m) |
| 2024-03-31 | (m) | $4.85M | $10.82M | (m) | $4.39M | $3.15M | (m) |
| 2023-12-31 | (m) | $4.45M | $11.48M | (m) | $4.05M | $3.48M | (m) |
| 2023-09-30 | (m) | $4.22M | $10.77M | (m) | $4.05M | $4.68M | (m) |
| 2023-06-30 | (m) | $4.08M | $11.72M | (m) | $3.64M | $5.28M | (m) |
| 2023-03-31 | (m) | $4.52M | $12.22M | (m) | $4.16M | $6.64M | (m) |
| 2022-12-31 | (m) | $6.96M | $17.41M | (m) | $3.56M | $6.40M | (m) |
| 2022-09-30 | (m) | $6.17M | $16.44M | (m) | $5.07M | $6.88M | (m) |
| 2022-06-30 | (m) | $5.73M | $18.27M | (m) | $4.08M | $6.77M | (m) |
| 2022-03-31 | (m) | $4.71M | $22.58M | (m) | $3.15M | $6.02M | (m) |
| 2021-12-31 | (m) | $4.79M | $25.33M | (m) | $3.59M | $6.11M | (m) |
| 2021-09-30 | (m) | $4.56M | $26.23M | (m) | $3.12M | $6.97M | (m) |
| 2021-06-30 | (m) | $3.31M | $26.54M | (m) | $2.58M | $7.56M | (m) |
| 2021-03-31 | (m) | $4.53M | $26.77M | (m) | $3.56M | $8.06M | (m) |
| 2020-12-31 | (m) | $3.67M | $27.32M | (m) | $2.57M | $6.83M | (m) |
| 2020-09-30 | (m) | $5.36M | $32.43M | (m) | $3.74M | $5.63M | (m) |
| 2020-06-30 | (m) | $8.30M | $38.13M | (m) | $2.97M | $3.67M | (m) |
| 2020-03-31 | (m) | $4.27M | $7.43M | (m) | $3.42M | $3.09M | (m) |
| 2019-12-31 | (m) | $2.41M | $5.87M | (m) | $3.23M | $2.39M | (m) |
| 2019-09-30 | (m) | $2.30M | $5.13M | (m) | $3.55M | $2.74M | (m) |
| 2019-06-30 | (m) | $1.87M | $3.81M | (m) | $3.29M | $2.57M | (m) |
| 2019-03-31 | (m) | $2.03M | $2.59M | (m) | $2.66M | $2.51M | (m) |
| 2018-12-31 | (m) | $1.58M | $3.74M | (m) | $1.43M | $2.10M | (m) |
| 2018-09-30 | (m) | $1.40M | $3.65M | (m) | $1.51M | $1.95M | (m) |
| 2018-06-30 | (m) | $1.55M | $3.42M | (m) | $1.84M | $1.72M | (m) |
| 2018-03-31 | (m) | $1.22M | $4.03M | (m) | $1.85M | $1.80M | (m) |
| 2017-12-31 | (m) | $1.59M | $3.97M | (m) | $1.86M | $1.66M | (m) |
| 2017-09-30 | (m) | $1.15M | $3.66M | (m) | $1.48M | $1.59M | (m) |
| 2017-06-30 | (m) | $869.08K | $2.98M | (m) | $1.90M | $1.27M | (m) |
| 2017-03-31 | (m) | (m) | $3.46M | (m) | (m) | (m) | (m) |
| 2017-02-28 | (m) | $1.39M | $3.31M | (m) | $1.50M | $1.35M | (m) |
| 2016-12-31 | (m) | (m) | $3.42M | (m) | (m) | (m) | (m) |
| 2016-11-30 | (m) | $1.63M | $3.44M | (m) | $1.66M | $1.30M | (m) |
| 2016-09-30 | (m) | (m) | $3.64M | (m) | (m) | (m) | (m) |
| 2016-08-31 | (m) | $1.41M | $3.97M | (m) | $1.35M | $1.07M | (m) |
| 2016-06-30 | (m) | (m) | $3.55M | (m) | (m) | (m) | (m) |
| 2016-05-31 | (m) | $1.25M | $3.86M | (m) | $1.35M | $1.12M | (m) |
| 2016-02-29 | (m) | $1.11M | $4.20M | (m) | $1.35M | $1.04M | (m) |
| 2015-11-30 | (m) | $1.14M | $3.34M | (m) | $1.76M | $1.26M | (m) |
| 2015-08-31 | (m) | $852.05K | $3.16M | (m) | $1.41M | $1.30M | (m) |
| 2015-05-31 | (m) | $904.21K | $2.47M | (m) | $1.47M | $1.41M | (m) |
| 2015-02-28 | (m) | $691.66K | $2.56M | (m) | $1.62M | $1.23M | (m) |
| 2014-11-30 | (m) | $1.19M | $2.25M | (m) | $1.71M | $1.57M | (m) |
| 2014-08-31 | (m) | $968.32K | $2.24M | (m) | $1.62M | $1.44M | (m) |
| 2014-05-31 | (m) | $1.05M | $2.34M | (m) | $1.65M | $1.02M | (m) |
| 2014-02-28 | (m) | $771.90K | $2.23M | (m) | $1.74M | $818.72K | (m) |
| 2013-11-30 | (m) | $505.88K | $1.92M | (m) | $1.28M | $956.01K | (m) |
| 2013-08-31 | (m) | $522.85K | $1.83M | (m) | $1.04M | $1.11M | (m) |
| 2013-05-31 | (m) | $469.10K | $1.63M | (m) | $943.77K | $1.26M | (m) |
| 2013-02-28 | (m) | $525.36K | $1.93M | (m) | $1.11M | $1.15M | (m) |
| 2012-11-30 | (m) | $669.74K | $1.68M | (m) | $1.19M | $1.17M | (m) |
| 2012-08-31 | (m) | $558.00K | $1.68M | (m) | $962.15K | $1.25M | (m) |
| 2012-05-31 | (m) | $485.40K | $1.73M | (m) | $736.99K | $1.32M | (m) |
| 2012-02-29 | (m) | $558.85K | $1.76M | (m) | $884.73K | $1.17M | (m) |
| 2011-11-30 | (m) | $561.61K | $1.57M | (m) | $878.16K | $1.06M | (m) |
| 2011-08-31 | (m) | $426.60K | $1.71M | (m) | $608.67K | $1.09M | (m) |
| 2011-05-31 | (m) | (m) | $1.63M | (m) | (m) | (m) | (m) |
| 2011-02-28 | (m) | $314.05K | $1.32M | (m) | $713.91K | $668.20K | (m) |
| 2010-11-30 | (m) | (m) | $1.36M | (m) | (m) | (m) | (m) |
| 2010-08-31 | (m) | (m) | $1.02M | (m) | (m) | (m) | (m) |
| 2010-02-28 | (m) | (m) | $813.38K | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lucid Diagnostics Inc. (LUCD) | United States | $0.170B | |
| Apyx Medical Corp (APYX) | United States | $0.120B | -21.85 |
| Profound Medical Corp. (PROF) | $0.206B | -7.37 | |
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| Pulmonx Corp (LUNG) | United States | $0.082B | -1.16 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |